Michael S. Willett

Michael S. Willett, PharmD, RAC provides more than 30 years of experience in clinical research. Dr. Willett started his career in a progressive hospital providing critical care, cardiology, infectious disease, nutritional team support and therapeutic drug monitoring. He transitioned into the industry and was involved in all phases of clinical research and multiple product launches at Marion Laboratories and Bristol-Myers Squibb. He moved to the CRO side of the industry in 1992 and founded Advanced Biomedical Research, Inc. (ABR) in 1994. ABR was a full-service Phase I-IV CRO and 72-bed Phase I-II clinical pharmacology unit focused on innovator compounds and complex studies. With an outstanding team of people, he built ABR into a medium-sized CRO and sold it to Frontage Laboratories in 2008. He then established Ready Clinical, LLC in 2009 as a clinical and regulatory consultancy. Dr. Willett received his Bachelor and Doctor of Pharmacy degrees from University of Illinois and completed an adult internal medicine residency at Truman Medical Center in Kansas City. He has maintained a regulatory affairs certification from Regulatory Affairs Professional Society (RAPS) since 2010. At AXIS Clinicals, Dr. Willett provides senior scientific input into the design and execution of early phase clinical trials. He is a member of RAPS and the Drug Information Association.